MRE-269
Product Specifications
CAS Number
475085-57-5
Target
Prostaglandin Receptor
Related Pathways
Immunology/Inflammation, GPCR/G Protein
Purity
0.9957
Bioactivity
MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 (ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269 (ACT-333679) is an active metabolite of Selexipag (S253150) .
Smiles
N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3
Molecular Formula
C25H29N3O3
Molecular Weight
419.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1242200-01 0.02 mg (E-Coli)
Recombinant Bartonella bacilliformis Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details MBS1242200-02 0.02 mg (Yeast)
Recombinant Bartonella bacilliformis Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details MBS1242200-03 0.1 mg (E-Coli)
Recombinant Bartonella bacilliformis Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details MBS1242200-04 0.1 mg (Yeast)
Recombinant Bartonella bacilliformis Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details MBS1242200-05 0.02 mg (Baculovirus)
Recombinant Bartonella bacilliformis Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details MBS1242200-06 0.02 mg (Mammalian-Cell)
Recombinant Bartonella bacilliformis Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details